Brighter announces that the subscription period for T06 will end on 1 November

Report this content

Brighter AB (Publ) (the Company) announced today that the subscription period for Brighter's warrant T06 will end on November 1, 2021, in accordance with the applicable terms.

The Company has received questions from shareholders regarding the possibility of extending the subscription period. Following information from Aktiemarknadsnämnden and recommendations from a number of financial and legal advisers, the Board has chosen not to pursue this. The reason, in brief, is that the board does not believe changing the terms would be in accordance with generally acceptable behaviour in the securities market, because no special circumstances are prevailing.

The Board has also decided not to start the redemption process whilst the share price is lower than the subscription price, as it is not economically rational for shareholders to exercise the options in such circumstances. However, the company has been prepared, throughout the subscription period, to act quickly if circumstances were to change to the benefit of the shareholders before 1 November.

For further information, please contact:
Investor Relations
IR@brighter.se
Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, 
+46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se
 
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighters quality management system is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.